Discovery of N-pyridazin-3-piperidine derivatives acting as p53 activators against breast cancer: In vitro and in silico evaluations

Aoxuan Zhang; Ben Zhong Tang; Siyu Zhou; Chengguang Sui; Shilin He; Yingying Liu; Mingdong Li; Yuqing Qian

doi:10.1016/j.bmc.2025.118410

Back

Discovery of N-pyridazin-3-piperidine derivatives acting as p53 activators against breast cancer: In vitro and in silico evaluations

Article 2025 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2015

In Silico Improvement of 3-Peptide Inhibitors of p53•hDM2 and p53•hDMX

Julien Michel, Elizabeth A. Harker, Julian Tirado‐Rives, William L. Jorgensen, Alanna Schepartz

Article2009

In Silico Improvement of β<sup>3</sup>-Peptide Inhibitors of p53•hDM2 and p53•hDMX

Julien Michel, Elizabeth A. Harker, Julian Tirado‐Rives, William L. Jorgensen, Alanna Schepartz

Journal of the American Chemical Society

Article2015

HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells

Lisha Xiang, Daniele M. Gilkes, Hongxia Hu, Weibo Luo, John W. Bullen, Houjie Liang, Gregg L. Friedman

Article2020

Azole derivatives with naphthalene showing potent antifungal effects against planktonic and biofilm forms of Candida spp.: an in vitro and in silico study

Suat Sarı, Ebru Koçak Aslan, Didem Kart, Zeynep Özdemir, M. Fahir Acar, Burcu Sayoğlu, Arzu Karakurt, Sevim Dalkara

Article2019

Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors

Dongwei Kang, Tong Zhao, Zhao Wang, Da Feng, Heng Zhang, Boshi Huang, Gaochan Wu, Fenju Wei, Zhongxia Zhou, Lanlan Jing, Xiaofang Zuo, Ye Tian, Vasanthanathan Poongavanam, Jacob Kongsted, De Clercq Erik, Christophe Pannecouque, Peng Zhan, Xinyong Liu